Windtree Therapeutics Announces Board and Executive Changes
Ticker: WINTW · Form: 8-K · Filed: Apr 18, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Windtree Therapeutics reshuffled its board and exec comp. Big changes ahead?
AI Summary
On April 17, 2025, Windtree Therapeutics, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates a shift in leadership and potential adjustments to how key personnel are compensated.
Why It Matters
Changes in a company's board and executive compensation can signal strategic shifts or reflect responses to performance, potentially impacting investor confidence and future operations.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate underlying issues or strategic realignments that may affect the company's future performance.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- April 17, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates changes in directors but does not specify the names of departing or newly appointed directors in the provided text.
Were there any changes to executive officer positions?
The filing mentions 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', suggesting potential changes to executive roles, but specific details are not in the provided text.
What is the nature of the changes in compensatory arrangements?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, indicating adjustments to executive pay, but the specifics of these arrangements are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 17, 2025.
What is Windtree Therapeutics, Inc.'s SIC code?
Windtree Therapeutics, Inc.'s Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).